Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?
Merck & Co., Inc., Rahway, NJ, USA (United States) · Medical University of Vienna · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
803
total citations
- FWCI
- 103.97
- Percentile
- 100%
- References
- 75
Citations per year
Authors
5- HEHans‐Georg EichlerCorresponding
Merck & Co., Inc., Rahway, NJ, USA (United States), Medical University of Vienna
- SXSheldon X. Kong
Merck & Co., Inc., Rahway, NJ, USA (United States)
- WCWilliam C. Gerth
Merck & Co., Inc., Rahway, NJ, USA (United States)
- PMPanagiotis Mavros
Merck & Co., Inc., Rahway, NJ, USA (United States)
- BJBengt Jönsson
Stockholm School of Economics
Topics & keywords
Topics
Keywords
- Health care
- Reimbursement
- Transparency (behavior)
- Rule of thumb
- Resource allocation
- Actuarial science
- Listing (finance)
- Decision analysis
No related works found for this paper.